In contrast, there was a trend toward a higher prevalence of BRCA2 mutations in the LTS cohort (13.9% vs 6.7%), although this difference did not reach statistical significance ( p = 0.182), Fig. 2 .
← all excerpts
Immuno-molecular features associated with exceptional recurrence-free survivorship from Ovarian Cancer in the pre-PARP era.
1
0.1820
0.1820